Born in New York, USA and raised in Athens, Greece, Telemaque Lavidas holds a BA economics degree from Columbia University, NY. In 2003, he joined Lavipharm Laboratories, the R&D arm in the USA, as Assistant Project Manager. In 2006, he assumed the position of Business Development Director and in 2009 he returned to Greece, where up to 2013 he managed all commercial operations of the Group as Chief Commercial Officer (CCO), responsible for five Business Units (BUs), Pharma Rx, ConsumerHealth, International, Wholesaling & 3rd Party Logistics, and pharmacy network services (Pharma PLUS). In 2013, he founded Mediterra, a fast-growing health food company based in NY. In 2021, he returned to Greece and he took helm of the Lavipharm Group, where he serves as Executive Board Member. He is a member of the General Committee of the Federation of Enterprises and Industries (SEV) and the Hellenic Association of Entrepreneurs (EENE). He is fluent in Greek, English, and French.
Telemaque Lavidas represents the 4th generation of the Lavidas family in the pharma industry, while he continues to perpetuate the pharmaceuticals business know-how successfully.